Protein Pop-Tarts, avocado oil chips: Are MAHA snacks really better for you?

A slew of new snacks promise better health outcomes, but do they deliver? ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  

April 25, 2026 Check out STAT+

Sponsored By

Good morning! Have we got a deal for you: Get 60% off your first year of STAT+ and gain unlimited access to our in-depth investigations, expert analysis, subscriber-only newsletters, and more. Thanks for reading!

Camille MacMillin/STAT Are MAHA snacks really better for you? Nutrition experts parse a grocery aisle gold rush From protein Pop-Tarts to avocado-oil chips, a MAHA-fueled snack revolution promises healthier eating. Nutrition experts say it may mostly be illusion. By Sarah Todd Christopher Lane for STAT Even for trans adults, care is hard to find: ‘I could not do it on my own’ Challenges at Savannah Pride Center highlight national issue: Policies targeting youth gender-affirming care leave trans adults with fewer options By Theresa Gaffney Thumỹ Phan for STAT STAT+ | Will bargain-basement telehealth visits help pharma drive drug scripts? Cheap telehealth visits advertised by pharma could steer patients toward expensive branded drugs, raising concerns about potential anti-kickback violations. By Katie Palmer STAT+ | The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna Stokes, survival time doubled. By Angus Chen Opinion: I started medical school at 69 and will begin residency at 72. Here’s what I learned Dawn Zuidegeest-Craft was a neonatal nurse practitioner for more than 40 years before getting her M.D. Here’s what she learned. By Dawn Zuidgeest-Craft STAT+ | Publicly, Kennedy embraces a more moderate MAHA Across seven congressional hearings, RFK Jr. lightened his messaging on vaccines and pesticides, but the MAHA impact on policy continues to be felt. By Daniel Payne and Chelsea Cirruzzo Psychedelics get a boost from the White House Ibogaine and other psychedelics are now being taken seriously for conditions like addiction and depression. STATus Report host Alex Hogan investigates. By Alex Hogan Opinion: Behind every miracle drug is a story Thomas Goetz, host of "Drug Story," on how his podcast explores the intersection of medication and modern life. By Torie Bosch

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Weekend Reads? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2026, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser